ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för astragaloside IV. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

25 träffar

Bibliografisk träff 2013-04-01

Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways.

Gui D, Huang J, Liu W, Guo Y, Xiao W, Wang N.

Apoptosis · research support, non-u.s. gov't; journal article · DOI 10.1007/s10495-013-0801-2

Bibliografisk träff 2012-11-03

The experimental study of Astragalus membranaceus on meridian tropsim: the distribution study of astragaloside IV in rat tissues.

Chang YX, Sun YG, Li J, Zhang QH, Guo XR, Zhang BL, Jin H, Gao XM.

J Chromatogr B Analyt Technol Biomed Life Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jchromb.2012.10.024

Bibliografisk träff 2012-10-03

Astragaloside IV attenuates Toll-like receptor 4 expression via NF-κB pathway under high glucose condition in mesenchymal stem cells.

Li M, Yu L, She T, Gan Y, Liu F, Hu Z, Chen Y, Li S, Xia H.

Eur J Pharmacol · controlled clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejphar.2012.09.033

Bibliografisk träff 2012-09-25

Astragaloside IV inhibits oxidative stress-induced mitochondrial permeability transition pore opening by inactivating GSK-3β via nitric oxide in H9c2 cardiac cells.

He Y, Xi J, Zheng H, Zhang Y, Jin Y, Xu Z.

Oxid Med Cell Longev · research support, non-u.s. gov't; research-article; journal article · DOI 10.1155/2012/935738

Bibliografisk träff 2012-09-17

Therapeutic effects of astragaloside IV on myocardial injuries: multi-target identification and network analysis.

Zhao J, Yang P, Li F, Tao L, Ding H, Rui Y, Cao Z, Zhang W.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0044938

Bibliografisk träff 2012-09-05

The effect of Astragaloside IV on immune function of regulatory T cell mediated by high mobility group box 1 protein in vitro.

Huang LF, Yao YM, Li JF, Zhang SW, Li WX, Dong N, Yu Y, Sheng ZY.

Fitoterapia · research support, non-u.s. gov't; journal article · DOI 10.1016/j.fitote.2012.08.019

Bibliografisk träff 2012-08-29

Astragaloside IV inhibited the activity of CYP1A2 in liver microsomes and influenced theophylline pharmacokinetics in rats.

Zhang YH, Zhang YJ, Guo YL, Li WJ, Yu C.

J Pharm Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1111/j.2042-7158.2012.01579.x

Bibliografisk träff 2012-08-08

Tanshinone IIA and astragaloside IV promote the migration of mesenchymal stem cells by up-regulation of CXCR4.

Xie J, Wang H, Song T, Wang Z, Li F, Ma J, Chen J, Nan Y, Yi H, Wang W.

Protoplasma · journal article · DOI 10.1007/s00709-012-0435-1

Bibliografisk träff 2012-08-01

[Protective effects of astragaloside IV on high-glucose-induced damage of retinal ganglion cells].

Hao M, Kuang HY, Fu Z, Gao XY, Li Y, Chen P, Wang Y.

Zhonghua Yi Xue Za Zhi · research support, u.s. gov't, non-p.h.s.; journal article

Bibliografisk träff 2012-06-22

Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo.

Gui D, Guo Y, Wang F, Liu W, Chen J, Chen Y, Huang J, Wang N.

PLoS One · research-article; journal article · DOI 10.1371/journal.pone.0039824

Bibliografisk träff 2012-05-28

Astragaloside IV Downregulates β-Catenin in Rat Keratinocytes to Counter LiCl-Induced Inhibition of Proliferation and Migration.

Li FL, Li X, Wang YF, Xiao XL, Xu R, Chen J, Fan B, Xu WB, Geng L, Li B.

Evid Based Complement Alternat Med · research-article; journal article · DOI 10.1155/2012/956107

Bibliografisk träff 2012-04-12

Effects of astragaloside IV on eosinophil activation induced by house dust mite allergen.

Gu X, Jiang D, Wang Y, Du Q, Cai J.

Mol Med Rep · journal article · DOI 10.3892/mmr.2012.869

Bibliografisk träff 2012-02-08

Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules.

Li M, Qu YZ, Zhao ZW, Wu SX, Liu YY, Wei XY, Gao L, Gao GD.

Neurochem Int · research support, non-u.s. gov't; journal article · DOI 10.1016/j.neuint.2012.01.026

Bibliografisk träff 2012-02-03

Analysis of saponins and phenolic compounds as inhibitors of α-carbonic anhydrase isoenzymes.

Koz Ö, Ekinci D, Perrone A, Piacente S, Alankuş-Çalişkan Ö, Bedir E, Supuran CT.

J Enzyme Inhib Med Chem · research support, non-u.s. gov't; journal article · DOI 10.3109/14756366.2011.651464

Bibliografisk träff 2012-01-26

Astragaloside IV prevents MPP⁺-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production.

Zhang ZG, Wu L, Wang JL, Yang JD, Zhang J, Zhang J, Li LH, Xia Y, Yao LB, Qin HZ, Gao GD.

Mol Cell Biochem · journal article · DOI 10.1007/s11010-011-1219-1

Bibliografisk träff 2012-01-04

Astragaloside IV inhibits apoptotic cell death in the guinea pig cochlea exposed to impulse noise.

Xiong M, He Q, Lai H, Wang J.

Acta Otolaryngol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.3109/00016489.2011.643457

Bibliografisk träff 2012-01-01

Topical astragaloside IV-releasing hydrogel improves healing of skin wounds in vivo.

Peng LH, Chen X, Chen L, Li N, Liang WQ, Gao JQ.

Biol Pharm Bull · research support, non-u.s. gov't; journal article · DOI 10.1248/bpb.35.881

Bibliografisk träff 2012-01-01

[Inhibitory effects of astragaloside IV on cytochrome P450 enzyme of rat liver microsomes].

Shan W, Zhang Y, Zhu J, Shao Q, Fan X.

Zhongguo Zhong Yao Za Zhi · research support, non-u.s. gov't; journal article

Bibliografisk träff 2011-12-21

Synergistic protective effect of astragaloside IV-tetramethylpyrazine against cerebral ischemic-reperfusion injury induced by transient focal ischemia.

Yang J, Li J, Lu J, Zhang Y, Zhu Z, Wan H.

J Ethnopharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jep.2011.12.023

Bibliografisk träff 2011-12-15

Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo.

Zhang Y, Hu G, Li S, Li ZH, Lam CO, Hong SJ, Kwan YW, Chan SW, Leung GP, Lee SM.

Mol Med Rep · research support, non-u.s. gov't; journal article · DOI 10.3892/mmr.2011.716

Bibliografisk träff 2011-11-28

The healing and anti-scar effects of astragaloside IV on the wound repair in vitro and in vivo.

Chen X, Peng LH, Li N, Li QM, Li P, Fung KP, Leung PC, Gao JQ.

J Ethnopharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jep.2011.11.035

Bibliografisk träff 2011-11-16

Astragaloside IV attenuates complement membranous attack complex induced podocyte injury through the MAPK pathway.

Zheng R, Deng Y, Chen Y, Fan J, Zhang M, Zhong Y, Zhu R, Wang L.

Phytother Res · research support, non-u.s. gov't; journal article · DOI 10.1002/ptr.3656

Bibliografisk träff 2011-11-14

Astragaloside IV and cycloastragenol stimulate the phosphorylation of extracellular signal-regulated protein kinase in multiple cell types.

Yung LY, Lam WS, Ho MK, Hu Y, Ip FC, Pang H, Chin AC, Harley CB, Ip NY, Wong YH.

Planta Med · research support, non-u.s. gov't; journal article · DOI 10.1055/s-0031-1280346

Bibliografisk träff 2003-11-01

Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression.

Zhang WJ, Hufnagl P, Binder BR, Wojta J.

Thromb Haemost · research support, non-u.s. gov't; journal article · DOI 10.1160/th03-03-0136

Bibliografisk träff 1997-07-01

Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expression.

Zhang WJ, Wojta J, Binder BR.

J Vasc Res · research support, non-u.s. gov't; journal article · DOI 10.1159/000159234